Qiagen NV
QGEN48.560USD
+1.340+2.84%
收盘 11/25, 16:00（美东）报价延迟15分钟
10.53B总市值
25.98市盈率 TTM
关于 Qiagen NV 公司
Qiagen NV 是一家总部位于荷兰的控股公司。该公司致力于提供从样本到洞察的解决方案，将生物样本转化为分子洞察。其从样本到洞察解决方案集成了样本和分析技术、生物信息学和自动化系统。其样本技术用于从血液或其他液体、组织、植物或其他材料中分离和制备脱氧核糖核酸 (DNA)、核糖核酸 (RNA) 和蛋白质。其分析技术使这些生物分子可见以供分析，例如识别病原体的遗传信息或肿瘤中的基因突变。其生物信息学解决方案解释数据以提供可操作的洞察。该公司基于聚合酶链反应 (PCR)、下一代测序 (NGS) 和其他技术的自动化平台将这些技术结合在一起，形成从样本到洞察的分子检测工作流程。
Qiagen NV简介
公司代码QGEN
公司名称Qiagen NV
上市日期Sep 01, 1996
CEOMr. Thierry Bernard
员工数量5765
证券类型Ordinary Share
年结日Sep 01
公司地址Hulsterweg 82
城市VENLO
上市交易所NYSE Consolidated
国家Netherlands
邮编5912 PL
电话31773556600
网址https://www.qiagen.com/
公司代码QGEN
上市日期Sep 01, 1996
CEOMr. Thierry Bernard
Qiagen NV公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
业务USD
名称
营收
占比
Consumables and Related Revenues
476.33M
89.28%
Instrumentation
57.21M
10.72%
地区USD
名称
营收
占比
United States
260.49M
48.82%
Europe & Middle East & Africa
179.30M
33.61%
Asia, Pacific & Rest of the World
73.46M
13.77%
Other Americas
20.29M
3.80%
业务
地区
业务USD
名称
营收
占比
Consumables and Related Revenues
476.33M
89.28%
Instrumentation
57.21M
10.72%
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Wellington Management Company, LLP
10.76%
MFS Investment Management
10.56%
The Vanguard Group, Inc.
4.30%
T. Rowe Price International Ltd
3.47%
DWS Investment GmbH
2.13%
其他
68.78%
持股股东
持股股东
占比
Wellington Management Company, LLP
10.76%
MFS Investment Management
10.56%
The Vanguard Group, Inc.
4.30%
T. Rowe Price International Ltd
3.47%
DWS Investment GmbH
2.13%
其他
68.78%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
48.71%
Investment Advisor
25.43%
Research Firm
5.08%
Pension Fund
1.63%
Sovereign Wealth Fund
1.60%
Hedge Fund
1.10%
Bank and Trust
1.09%
Individual Investor
0.44%
Insurance Company
0.05%
其他
14.86%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
996
177.81M
82.00%
-32.33M
2025Q2
996
189.55M
87.53%
+6.64M
2025Q1
1017
179.03M
82.67%
+27.58M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Wellington Management Company, LLP
26.02M
12%
+1.59M
+6.49%
Jun 30, 2025
MFS Investment Management
23.48M
10.83%
-787.04K
-3.24%
Jun 30, 2025
The Vanguard Group, Inc.
9.16M
4.22%
+372.54K
+4.24%
Jun 30, 2025
T. Rowe Price International Ltd
5.94M
2.74%
+1.79M
+43.10%
Jun 30, 2025
DWS Investment GmbH
3.30M
1.52%
+2.74M
+482.72%
Jun 30, 2025
EARNEST Partners, LLC
4.20M
1.94%
+395.58K
+10.39%
Jun 30, 2025
Amundi Asset Management, SAS
3.98M
1.83%
-217.72K
-5.19%
Jun 30, 2025
Boston Partners
2.36M
1.09%
+13.48K
+0.58%
Aug 31, 2025
BlackRock Institutional Trust Company, N.A.
20.54M
9.47%
+174.28K
+0.86%
Sep 10, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
First Trust Nasdaq Lux Digi Health Solutions ETF
3.85%
Global X Genomics & Biotechnology ETF
3.76%
Invesco Biotechnology & Genome ETF
2.45%
VanEck Biotech ETF
1.81%
ROBO Global Healthcare Technology & Innovation ETF
1.46%
Pacer US Large Cap Cash Cows Growth Leaders ETF
1.18%
Franklin Genomic Advancements ETF
1%
iShares Health Innovation Active ETF
0.93%
Burney US Factor Rotation ETF
0.75%
WisdomTree International Multifactor Fund
0.68%
查看更多
First Trust Nasdaq Lux Digi Health Solutions ETF
占比3.85%
Global X Genomics & Biotechnology ETF
占比3.76%
Invesco Biotechnology & Genome ETF
占比2.45%
VanEck Biotech ETF
占比1.81%
ROBO Global Healthcare Technology & Innovation ETF
占比1.46%
Pacer US Large Cap Cash Cows Growth Leaders ETF
占比1.18%
Franklin Genomic Advancements ETF
占比1%
iShares Health Innovation Active ETF
占比0.93%
Burney US Factor Rotation ETF
占比0.75%
WisdomTree International Multifactor Fund
占比0.68%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
公告日期
类型
比率
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
常见问题
Qiagen NV的前五大股东是谁？
Qiagen NV 的前五大股东如下：
Wellington Management Company, LLP持有股份：26.02M，占总股份比例：12.00%。
MFS Investment Management持有股份：23.48M，占总股份比例：10.83%。
The Vanguard Group, Inc.持有股份：9.16M，占总股份比例：4.22%。
T. Rowe Price International Ltd持有股份：5.94M，占总股份比例：2.74%。
DWS Investment GmbH持有股份：3.30M，占总股份比例：1.52%。
Wellington Management Company, LLP持有股份：26.02M，占总股份比例：12.00%。
MFS Investment Management持有股份：23.48M，占总股份比例：10.83%。
The Vanguard Group, Inc.持有股份：9.16M，占总股份比例：4.22%。
T. Rowe Price International Ltd持有股份：5.94M，占总股份比例：2.74%。
DWS Investment GmbH持有股份：3.30M，占总股份比例：1.52%。
Qiagen NV的前三大股东类型是什么？
Qiagen NV 的前三大股东类型分别是：
Wellington Management Company, LLP
MFS Investment Management
The Vanguard Group, Inc.
Wellington Management Company, LLP
MFS Investment Management
The Vanguard Group, Inc.
有多少机构持有Qiagen NV(QGEN)的股份？
截至2025Q3，共有996家机构持有Qiagen NV的股份，合计持有的股份价值约为177.81M，占公司总股份的82.00%。与2025Q2相比，机构持股有所增加，增幅为-5.53%。
哪个业务部门对Qiagen NV的收入贡献最大？
在FY2025Q2，Consumables and Related Revenues业务部门对Qiagen NV的收入贡献最大，创收476.33M，占总收入的89.28%。
